close
MENU
Hot Topic Hawke’s Bay
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Hawke’s Bay
Investment
3 mins to read

TruScreen flags it needs to raise capital again, shortly

Cervical cancer screening technology company's board warns if it doesn't raise money by next September, it may not survive.

TruScreen chair Anthony Ho.

NBR Staff Fri, 29 Nov 2024
Key points
  • Revenue: Up 5% to $1m
  • Profit: Improved 16.4% to $1.36m
  • Main takeaway: China and Vietnam key first steps for dual-listed company, but it is running short of capital to achieve goals. 

Kiwi cervical cancer screening device company TruScreen says it is at a "turning point" in the commercialisation of its technology, as it contemplates burgeoning sales avenues in China and Vietnam – but it needs capital urgently to achieve these goals. 

The NZX and ASX-listed company this morning

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
NBR Staff Fri, 29 Nov 2024
Contact the Writer: editor@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
TruScreen Group medical devices Cancer screening cervical cancer
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

TruScreen will look to raise capital, again
Investment
3

TruScreen to raise more capital after another ‘going concern’ tag
Comings & Goings

Truscreen appoints new CEO
Investment

TruScreen plans capital raise as auditors flag going concern
Investment

TruScreen considering options as it runs short on cash
Key points
  • Revenue: Up 5% to $1m
  • Profit: Improved 16.4% to $1.36m
  • Main takeaway: China and Vietnam key first steps for dual-listed company, but it is running short of capital to achieve goals. 
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

TruScreen will look to raise capital, again
Investment
3

TruScreen to raise more capital after another ‘going concern’ tag
Comings & Goings

Truscreen appoints new CEO
Investment

TruScreen plans capital raise as auditors flag going concern
Investment

TruScreen considering options as it runs short on cash
TruScreen flags it needs to raise capital again, shortly
Investment,
106946
true
Subscribe Login